Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Actiq oral transmucosal fentanyl citrate data

Researchers presented Phase III results at the American Society of Clinical Oncology in Denver of two trials designed to show that Actiq could control breakthrough pain

Read the full 262 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE